Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1639

Mar 10, 2020

Experts: Rapid testing helps explain few German virus deaths

Posted by in category: biotech/medical

BERLIN (AP) — Germany has confirmed more than 1,100 cases of the new coronavirus but — so far — just two deaths, far fewer than other European countries with a similar number of reported infections.

Experts said Monday that rapid testing as the outbreak unfolded meant Germany has probably diagnosed a much larger proportion of those who have been infected, including younger patients who are less likely to develop serious complications.

That’s given authorities more chance of containing the virus, and more time to prepare for it.

Mar 10, 2020

A Disease Tracker Backed by Gates and Zuckerberg Tackles Covid-19

Posted by in category: biotech/medical

The two tech titans funded an effort to bring metagenomic sequencing and software to poor countries. Now, it’s helping trace the spread of the new coronavirus.

Mar 10, 2020

The Truth About Blood Thinners

Posted by in category: biotech/medical

From Consumer Reports, what you need to know about the newer blood thinners, including how to take these meds safely and effectively.

Mar 10, 2020

Coronavirus ‘worse than a bomb’ on Italy, says doctor coordinating response

Posted by in categories: biotech/medical, government, health

Giacomo Grasselli — a senior Italian government health official who is coordinating the network of intensive care units in Lombardy — explains the “critical” situation in Italy, brought about by the Covid-19 outbreak (Subscribe: https://bit.ly/C4_News_Subscribe)

——

Continue reading “Coronavirus ‘worse than a bomb’ on Italy, says doctor coordinating response” »

Mar 10, 2020

Scarcity Of Health Workers A New Concern As Self-Quarantining Spreads With Virus

Posted by in categories: biotech/medical, health

Coronavirus Spread Spurs Debate Over Which Health Workers Need To Be Quarantined : Shots — Health News Should “potential exposure” by a health worker to someone with coronavirus be enough to send that worker home for two weeks of self-quarantine? Health systems have begun debating relative risks.

Mar 10, 2020

NASA center in California issues mandatory work-from-home order after employee tests positive for coronavirus

Posted by in categories: biotech/medical, policy

NASA’s Ames Research Center in California has issued a mandatory policy for employees to work from home after one worker tested positive for the coronavirus responsible for COVID-19.

The research center, which is located in Moffett Field in the Silicon Valley, has been placed on restricted access after the employee was confirmed to have the coronavirus on Sunday (March 8).

Mar 10, 2020

Continuous Glucose Monitoring System

Posted by in categories: biotech/medical, electronics

https://youtube.com/watch?v=QKi5T4uTGXk

Check your blood glucose without fingersticks using the FreeStyle Libre System, a continuous glucose monitoring system that includes a sensor and reader.

Mar 10, 2020

Scientists single out gene that triggers aging symptoms

Posted by in categories: biotech/medical, life extension

Circa 2018 we need crispr pills for this.


The steady march of aging might not have to be so steady, according to a growing body of research. Now a team from the University at Buffalo has isolated a single gene that controls senescence, the process that stops cells from dividing and contributes to aging symptoms. Ramping it up, they found how easily the effect can spread among neighboring cells. That makes the gene a crucial target for future work into anti-aging and cancer therapies.

Living cells have a natural limit to the amount of times they can divide, before they stop and become what are known as senescent cells. The problem is, over time these senescent cells build up in the body, eventually contributing to the physical symptoms we associate with aging, such as increased risk of diabetes, heart disease, arthritis and cataracts. On the other hand though, completely halting senescence can lead to cancer, as the cells continue to divide unchecked.

Continue reading “Scientists single out gene that triggers aging symptoms” »

Mar 10, 2020

Econogenomics: The Economics of Genomic Testing for Health

Posted by in categories: biotech/medical, economics, health

Let’s say it was possible to buy your health by the day. How much would you be willing to pay for each year of perfect health? What if you could buy years of health for your loved ones, too? At what price point would you draw the line?

This sort of difficult calculus, on a much larger and chronologically longer scale, underpins many decisions we make in medicine — not just decisions that we make as patients, but also the decisions that are made for us by employers, health insurance funders and policymakers. We don’t have the resources to pursue every possible treatment, to research every possible breakthrough, so how do we allocate the resources available? It turns out that there is an entire field of healthcare economics devoted to understanding the costs and benefits of conventional medicine, and to navigating the trade-offs between more expense and better healthcare.

Continue reading “Econogenomics: The Economics of Genomic Testing for Health” »

Mar 10, 2020

Success in Reprogramming a Supercentenarian’s Cells

Posted by in categories: biotech/medical, life extension

Researchers from AgeX Therapeutics and other organizations have proved the feasibility of reprogramming banked cells derived from a supercentenarian. Their discovery portends exciting new possibilities for aging research.

What is cellular reprogramming?

Cellular reprogramming is the process of reverting mature, specialized cells into induced pluripotent stem cells (iPSCs), which can develop into any cell type found in the human body. Cellular reprogramming technology was pioneered in 2006 by Drs. Takahashi and Yamanaka, who achieved this impressive result by overexpressing just four genes, Oct4, Sox2, Klf4, and c-Myc (OSKM), which became collectively known as the Yamanaka factors. For this breakthrough, Yamanaka was awarded the Nobel Prize in 2012. Fun fact: Yamanaka called these cells iPSCs – with a small “i” – as a nod to the iPod and similarly named devices.